MDA’s translational research program represents an innovative way to fund research that’s designed to move new drug targets into the clinic as rapidly and efficiently as possible.
The program was developed in response to the increasing number of promising therapeutic avenues for neuromuscular diseases that have developed from MDA's basic research program. The program focuses on key areas MDA has identified as critical weaknesses in the drug development process for rare diseases.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.